Navigation Links
Winner Medical Group Inc. to Present at the Rodman & Renshaw Annual Global Investment Conference on September 13 at 3:40 pm ET
Date:9/8/2010

i class="">Contact PR Newswire Health Care & Hospitals, Health Insurance, Medical Equipment, Pharmaceuticals, Trade Show News Click to view news release full screen  

Winner Medical Group Inc. to Present at the Rodman & Renshaw Annual Global Investment Conference on September 13 at 3:40 pm ET

 

SHENZHEN, China, Sept. 8 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: WWIN; "Winner Medical"), a leading manufacturer of medical dressings, medical disposables and non-woven PurCotton(R) materials for the medical and consu
'/>"/>

SOURCE Winner Medical Group Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Grammy Winner Marc Cohn to Perform for African AIDS Organization at Carolina HopeFest
2. GeoVax Labs, Inc. Selected by Georgia Bio as 2008 Deal of the Year Award Winner in Life Sciences Industry
3. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
4. Olympic Winner Xiong Ni, Spokesperson for Endoscopic Medicine -- Chinese Minimally Invasive Advanced Technology Top in the World
5. The Scientist Magazine Recognizes febits HybSelect(TM) Among the Winners of Top 10 Innovations of 2009
6. Bayer Express Your Simple Win Creativity Contest Grand Prize Winners Announced
7. Winner Medical Participates in CMEF 2010, China International Medical Equipment Fair, in Shenzhen
8. Lakeside Behavioral Healthcare Named Winner of First Annual Netsmart Technologies Customer Innovation Award
9. Winner Medical Group Inc. Announces Closing of $8.4 Million Public Offering of Common Stock
10. NYU-Poly Professor Among First Winners of BioAccelerate NYC Prize; Project May Move Diagnostic Medicine from the Lab to the Palm of a Hand
11. Winner Medical Group Inc. to Host Second Quarter Fiscal Year 2010 Earnings Conference Call on Tuesday, May 11, 2010 at 5:00 p.m. EDT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)...  OrthoSpace Ltd. ("OrthoSpace" or "Company") announced today ... its US Investigational Device Exemption (IDE) pivotal study.  ... blinded control study that compares the Company,s InSpace ... repair for the treatment of full thickness massive ... available outside of the United States ...
(Date:7/6/2015)... , July 6, 2015 /CNW/ - The Canadian Pharmacists Association ... immunization strategy to ensure that all Canadians have the ... HPV (human papillomavirus) through immunization. The lack of access ... Canada is needlessly putting the health ... such as HPV, continue to pose a significant threat ...
(Date:7/6/2015)... 6, 2015 Mauna Kea ... multidisciplinary confocal laser endomicroscopy platform, announced today it ... Ministry of Health, Labor and Welfare (MHLW) ... the AQ-Flex 19 miniprobe.   Used ... miniprobe is comprised of a fiber-optic microscope that ...
Breaking Medicine Technology:OrthoSpace Enrolls First Patients in US IDE Study 2CPhA Calls for HPV Strategy for Young Men to Save Lives 2Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 2Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 3
(Date:7/7/2015)... , ... July 07, 2015 , ... America is blessed ... California Casualty’s Nominate A Hero program offers a special way to say “thanks.” ... hero receives a $250 gift card and their place on the “Wall of Heroes.” ...
(Date:7/7/2015)... AURORA, Colo. (PRWEB) , ... ... ... healthcare landscape relies on highly educated and motivated leaders with strong managerial ... how well they clearly communicate with patients, staff, providers, business partners, insurance ...
(Date:7/7/2015)... Toronto, ON (PRWEB) , ... July 07, 2015 , ... ... which is effective immediately and permits the use of gluten-free claims for gluten free ... the prospect of expanding the Gluten-Free Certification Program (GFCP) to include gluten-free ...
(Date:7/7/2015)... ... July 07, 2015 , ... CSG ... have been selected by the Department of Vermont Health Access to provide Quality ... Information System (MMIS) and Integrated Contact Center System project. , Vermont is implementing ...
(Date:7/6/2015)... , ... July 06, 2015 , ... ... pre-clinical stages of drug discovery. iPSCs are generated from adult cells, such as ... any cell type in the human body. , iPSC-derived cardiomyocytes ...
Breaking Medicine News(10 mins):Health News:California Casualty Wants to Know: "Who Is Your Hero?" 2Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 2Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 3Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 4Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 2Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 3Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 4Health News:CSG Government Solutions Selected by the Department of Vermont Health Access to Provide Quality Assurance and Independent Verification and Validation Services 2Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 2Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 4
... the damage to their lungs that exacerbates asthmatic symptoms just ... the University of Groningen in the Netherlands. The ... American Thoracic Society,s American Journal of Respiratory and Critical ... smoke appears to increase the thickness of the epithelium, or ...
... become a mainstay of multiple myeloma treatment may outperform ... who have received stem cell transplants from unrelated, partially ... be presented by Dana-Farber Cancer Institute investigators ... on Sunday, Dec. 6 (Abstract 48, Ernest N. Morial ...
... College of Wisconsin, in Milwaukee, found a substantial variation ... disease complications in children. Barriers to its use on ... identified. The study led by Amanda M. Brandow, ... College and Children,s Research Institute at the Children,s Hospital ...
... Hamilton, ON. Dec. 6, 2009 A new study provides ... as venous thromboembolism (VTE). The condition is estimated ... occurs when an abnormal clot forms in a vein and ... some cases, the clot may detach from its point of ...
... NEW ORLEANSA new three-drug combination has shown in a phase ... regimen" in the treatment of patients newly diagnosed with multiple ... say researchers from Dana-Farber Cancer Institute. Partial responses or ... with the drug combination in the multi-center study, with 74 ...
... , --In Youngest ... , PHILADELPHIA and NEW ORLEANS, Dec. 5 Pediatric ... with another gene to drive an often-fatal form of leukemia ... expect to better predict which infants may benefit from particular ...
Cached Medicine News:Health News:Quitting smoking can reverse asthma-inducing changes in lungs 2Health News:Bortezomib shows promise in reducing GVHD and reconstituting immune system in some patients 2Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: